How to Buy Revance Therapeutics Stock
Revance Therapeutics Inc
Revance Therapeutics, Inc. , a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally.
Revance Therapeutics stock last closed at $3.29, down 7.84% from the previous day, and has decreased 89.6% in one year. It has underperformed other stocks in the Biotechnology industry by 0.66 percentage points. Revance Therapeutics stock is currently +1.86% from its 52-week low of $3.23, and -91.34% from its 52-week high of $37.98.
There are currently 88.21M RVNC shares outstanding. The market value of RVNC is $290.22M. In the last 24 hours, 2.63M RVNC shares were traded.
How to Buy Revance Therapeutics Stock
Wondering how to invest in Revance Therapeutics stock? Here's how.
- Choose where to buy Revance Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Revance Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Select your method of payment and add your details.
- Analyze Revance Therapeutics stock: The Revance Therapeutics ticker symbol is RVNC. Is Revance Therapeutics stock a good investment? Should you buy shares of RVNC? How do RVNC's underlying business fundamentals look? Do top analysts think Revance Therapeutics is a good buy? Why has RVNC's stock price moved recently? (Hint: Our stock research website can help you understand if RVNC is a good stock to buy).
- Make your RVNC buy order: Decide if you will purchase RVNC shares at the current market price or use a limit order to buy RVNC shares at a specific price.
- Track your RVNC investment: Create a watchlist to important updates regarding your investment in Revance Therapeutics shares.
Step 1: Choose where to buy Revance Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy RVNC stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to buy RVNC today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new brokerage account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock broker app, you need to deposit funds:
Watch the walkthrough below for more details transferring funds into your new investment account.
Step 4: Analyze Revance Therapeutics stock
Once you have figured out the best place to buy Revance Therapeutics stock, it's very important to evaluate their stock before you buy, so you actually wrap your head around the risk as well as the opportunity.
Revance Therapeutics Metrics
RVNC Overview
WallStreetZen was created to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on RVNC's stock page.
Is RVNC stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge RVNC's true value.
You can access additional valuation analysis on RVNC's stock here.
RVNC Financial Health
Positive Financial Indicators:
- RVNC has cash burn of 223461000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the RVNC balance sheet.
Negative Financial Indicators:
- RVNC profit margin has gone up by 1.31 percentage points in the past year, but the company is still unprofitable.
- There are more long-term liabilities than short-term assets on the RVNC balance sheet.
- RVNC has $254.47M in cash and short term investments. This is not sufficient to cover its annual cash burn of $223.46M.
- RVNC debt to equity ratio of -4.16 is negative.
- Total RVNC debt is still negative.
Do analysts think it's a good time to buy Revance Therapeutics stock
Out of 7 Wall Street analysts who research RVNC, the consensus analyst rating on RVNC is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest RVNC Analyst Forecasts
Vamil Divan, a top 5% analyst from Mizuho downgrades RVNC to a hold rating and lowers their RVNC price target from $16.00 to $9.00, on Jan 29, 2024.
Uy Ear, a bottom 10% analyst from Mizuho maintains RVNC with a strong buy rating and lowers their RVNC price target from $35.00 to $16.00, on Nov 22, 2023.
You can dive deeper into what analysts are forecasting on the Revance Therapeutics stock forecast page.
RVNC Trading Indicators
RVNC Revenue
Last year, RVNC revenue was $234.04M. Over the last 5 year, RVNC's revenue has increased by 128.84% per year. This was faster than the Biotechnology industry average of 28.62%.
Dig into RVNC's earnings and revenue performance here.
Latest Insiders Trades at RVNC
In the past 12 months, executives and large shareholders at RVNC have sold more shares than they have bought.
Erica Jordan, Chief Commercial Officer of RVNC, was the latest RVNC insider to sell. They sold $9,096.78 worth of RVNC shares on Apr 16, 2024.
Dig into more about who owns RVNC shares here.
Does RVNC stock generate passive income?
No, Revance Therapeutics doesn't provide an income stream by paying out dividends.
RVNC Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your RVNC buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price, place a limit order.
Press the Open button and eToro will place your order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Track your RVNC investment
Now that you own some RVNC shares, you'll want to keep up with your stock purchase.
Start a watchlist to keep tabs on your RVNC stock.
RVNC Feed
How to Buy Stock in Revance Therapeutics
To summarize, here are the 6 steps for buying Revance Therapeutics stock:
- Choose where to buy Revance Therapeutics stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Analyze Revance Therapeutics stock
- Make your RVNC buy order
- Track your RVNC investment
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your new investment in Revance Therapeutics, add RVNC to your watchlist by clicking the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.